Soft Tissue Fixation Rebounds in Q123 To Start the Year In a Positive Direction
In Q1, the STF market experienced notable growth, primarily driven by several factors, including an increase in elective procedures, a decrease in the effects of supply chain issues and increased growth over a sluggish Q122. Overall, these factors collectively propelled the STF market to exhibit robust growth during the first quarter.
Among the many topics covered in detail inSmartTRAK's comprehensiveQ123 Soft Tissue Fixation Market Recap* are:
- Complete Q123 Soft Tissue Fixation Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All STF Companies' News, Revenues, Data, Charts and Market Shares
- Headwinds and Tailwinds
- Top Competitor Results & Highlights
- Q123 Clinical/Regulatory Highlights
In the first quarter of 2023, the orthopedic ambulatory surgical center (ASC) market in the US experienced positive developments. The market witnessed significant growth in personnel, contracts and portfolio expansion within Sports Medicine companies. In their Q1 earnings call, Zimmer Biomet* COO Ivan Tornos commented that ...
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
